Alegeus Unveils High-Yield Feature for WealthCare HSA Solution, Providing Account Holders Lucrative Opportunities to Maximize Fund Values

Backed by Pacific Life, new enhanced interest option has the potential to earn account holders up to 10 times their current HSA cash account interest rate WALTHAM, Mass.–(BUSINESS WIRE)–#HSA—Alegeus, the market leader in healthcare payment solutions, today unveiled WealthCare HSA High-Yield, an innovative enhanced interest option that has the potential to earn account holders up … [Read more…]

Navitus Health Solutions Receives URAC Accreditation In Pharmacy Benefit Management

MADISON, Wis.–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, announced today that it has again been granted full URAC accreditation for Pharmacy Benefit Management. URAC is the independent leader in promoting health care quality by setting high standards for … [Read more…]

Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients

First Pediatric Study to Evaluate Use of AlloSure dd-cfDNA as Biomarker for Allograft BK Infection Findings Add to Growing Body of Evidence Showing Clinical Value of AlloSure for Surveillance in Pediatric Kidney Transplant Patients BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value … [Read more…]

Bloomberg’s Drew Armstrong Joins Endpoints as Executive Editor to Lead Expansion

NEW YORK–(BUSINESS WIRE)–#appointment—Endpoints announced today that Drew Armstrong has been appointed Executive Editor. In this newly created role, Armstrong will lead the expanding editorial team and help direct the company’s next growth phase into premium news and subscription data products, new events and tools for connecting the biopharma world. Armstrong was most recently Bloomberg’s Senior … [Read more…]

Receptor Life Sciences Opens Second Investigational New Drug (IND) Application with FDA for RLS103 (Inhaled Dry Powder CBD) for the Treatment of Rapid Epileptic Seizure Termination (REST)

SEATTLE–(BUSINESS WIRE)–Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, is expanding the potential clinical utility of RLS103 into epilepsy. A proof-of-concept clinical safety and efficacy study in epilepsy will be conducted under a second, recently opened IND application. The Phase 1b randomized, double-blind, placebo-controlled, crossover study will … [Read more…]

Global Viral Vector Production Market Report 2022: Technological Breakthroughs in Vector Manufacturing and a Reliable Pipeline for Gene Treatments and Viral Vector Vaccinations Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Viral Vector Production Market Analysis by Vector Type, by Application, by Workflow, End user and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The viral vector production market size is estimated to be USD 673.4 million in 2021 and is expected to witness a CAGR of 22.72% … [Read more…]

Forescout Launches Forescout Assist to Empower Organizations with 24/7 Threat Detection, Investigation and Response Expertise and Capabilities

New subscription service combines machine automation and human expertise to identify high priority threats and risks, and provide recommended remediation SAN JOSE, Calif.–(BUSINESS WIRE)–Forescout Technologies, Inc., the global leader in automated cybersecurity, today launched Forescout Assist for Healthcare and Forescout Assist for OT/ICS, new subscription services that provide organizations’ IT security and engineering teams access … [Read more…]

Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced a variety of educational campaigns and activities in recognition of National Diabetes Awareness Month and World Diabetes Day. “Our team is relentless in our mission to improve the lives … [Read more…]

Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity

Impact investment firm focuses on investing in therapies for diseases that disproportionately affect underserved populations, including ethnic minorities and the LGBTQ+ community NEW YORK–(BUSINESS WIRE)–Syridex Bio (“Syridex” or “the Firm”), an impact-driven, life sciences-focused firm investing in therapies that address the needs of underserved communities, has officially launched. The firm’s founding, by a team of … [Read more…]

United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR) announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company’s business during a fireside chat session at the Credit Suisse 31st Annual Healthcare Conference in Los Angeles. The session will take place on … [Read more…]